| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/11/2006 | CN1235910C Target-specific cytotoxin chimeric with short-peptide harmone |
| 01/11/2006 | CN1235909C Recombination human interferon alpha 8 polypeptide coding cDNA sequence, preparation method and application |
| 01/11/2006 | CN1235875C Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 01/11/2006 | CN1235641C Medicinal aerosol formulation, its preparing process, use and inhaler containing same |
| 01/11/2006 | CN1235638C Activated protein C formulations |
| 01/11/2006 | CN1235637C Methods for treating diabetes |
| 01/11/2006 | CN1235570C Microball preparation for intestine orient releasing medicine and its preparing method |
| 01/10/2006 | US6984773 Transgenic mice expressing a human SXR receptor polypeptide |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984719 Peptide antagonists of prostaglandin F2α receptor |
| 01/10/2006 | US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/10/2006 | US6984628 Ophthalmic compositions comprising trefoil factor family peptides |
| 01/10/2006 | US6984627 Peptide derivatives |
| 01/10/2006 | US6984626 For therapy and prophylaxis of Alzheimer's disease |
| 01/10/2006 | US6984625 Methods and compositions for modulating autoimmunity |
| 01/10/2006 | US6984624 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof |
| 01/10/2006 | US6984623 Tendon-inducing compositions |
| 01/10/2006 | US6984622 Applying a therapeutically effective amount of a beta -defensin polypeptide to the wound for therapy of wounds in mammalian tissue, to promote wound healing |
| 01/10/2006 | US6984621 Wound contraction inhibitor |
| 01/10/2006 | US6984509 Steroid dehydrogenase 34 and the polynucleotide encoding same |
| 01/10/2006 | US6984504 Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons |
| 01/10/2006 | US6984502 Methods and compositions of human 69087 nucleic acids and uses thereof |
| 01/10/2006 | US6984501 used in test systems which are suitable for identifying substances modulating, opening or closing the Kv2,1/Kv6.2 channels and which can be used as therapeutic agents |
| 01/10/2006 | US6984493 Method for examining the involvement of opioid peptides in prurtis |
| 01/10/2006 | US6984490 Identification of genes |
| 01/10/2006 | US6984488 Determination and control of bimolecular interactions |
| 01/10/2006 | US6984406 Useful as an additive for feeds and in the decomposition of hemicellulose |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | US6984389 Administering to a cancer patient at least one treatment modality, containing a tyrosine kinase inhibitor and a purified heat shock protein to cure the cancer |
| 01/10/2006 | US6984385 Immunological combination compositions and methods |
| 01/10/2006 | US6984384 A biodrug mixture contains a preheated fusion protein,comprising heat shock protein, glucose-regulated protein and immuogens; antigrowth agents; cancer, tuberculosis infection |
| 01/10/2006 | US6984382 Bifunctional protein, preparation and use |
| 01/10/2006 | US6984380 Therapeutic treatment or preventing autoimmune diseases, diabetes; removing cells from individual, transfecting the removed cells with DNA encoding normal major histocompatibility complex, reinfusing the transfected cells into body |
| 01/10/2006 | US6984128 Methods for enabling and stabilizing tooth movement |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2189831C Dna-based vaccination of fish by immersion |
| 01/10/2006 | CA2157590C Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 01/10/2006 | CA2114353C Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/10/2006 | CA2081043C Antitumor vaccines comprising il-6 transfected cells |
| 01/08/2006 | CA2511711A1 Liquid pharmaceutical formulations of octreotide, manufacturing process and container for the same |
| 01/08/2006 | CA2473412A1 Liquid pharmaceutical injectable formulation of octreotide |
| 01/05/2006 | WO2006002387A2 Gdf3 propeptides and related methods |
| 01/05/2006 | WO2006002203A2 Methods and compositions for the treatment of polycystic diseases |
| 01/05/2006 | WO2006002195A2 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 01/05/2006 | WO2006002050A1 Phospholipid compositions and methods for their preparation and use |
| 01/05/2006 | WO2006001982A2 Methods and compositions for treating neuropathies |
| 01/05/2006 | WO2006001981A2 Methods for treating disease by modulating an osmotic stress pathway |
| 01/05/2006 | WO2006001963A1 Pharmaceutical compositions comprising cyclosporins |
| 01/05/2006 | WO2006001956A2 Compositions for inhibiting cell growth and inducing apoptosis in cancer cells and methods of use thereof |
| 01/05/2006 | WO2006001810A2 Improved inhibitor nucleic acids |
| 01/05/2006 | WO2006001729A1 Peptide substance restoring respiratory organs function |
| 01/05/2006 | WO2006001728A1 Peptide substance restoring myocardium function |
| 01/05/2006 | WO2006001582A1 Cell-killing peptide |
| 01/05/2006 | WO2006001499A2 Metastin derivatives and use thereof |
| 01/05/2006 | WO2006001382A1 Method of producing dipeptide or dipeptide derivative |
| 01/05/2006 | WO2006001379A1 Method of producing dipeptide |
| 01/05/2006 | WO2006000867A1 Compositions for topical treatment |
| 01/05/2006 | WO2006000753A2 Use of flj40787, a protein involved in colon, colorectal, ovarian, lung and/or liver cancer |
| 01/05/2006 | WO2006000567A2 Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function |
| 01/05/2006 | WO2006000397A1 Novel use of peptide compounds for treating essential tremor and other tremor syndromes |
| 01/05/2006 | WO2006000007A1 Use of peptides derived from the a alpha or b beta chain of human fibrinogen for the treatment of shock |
| 01/05/2006 | WO2005115438B1 Use of morphogenic proteins for treating cartilage defects |
| 01/05/2006 | WO2005112974A3 Peptide-modified polyurethane compositions and associated methods |
| 01/05/2006 | WO2005095450A3 Therapeutic use of a growth factor, nsg33 |
| 01/05/2006 | WO2005089070A3 Thrombin derivatives and medicinal composition containing the same |
| 01/05/2006 | WO2005074996A3 Lat1 transporter expressed in blood brain barrier cells |
| 01/05/2006 | WO2005072139A3 Use of aerosolized antithrombin to treat acute lung injury |
| 01/05/2006 | WO2005071070A3 Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors |
| 01/05/2006 | WO2005066867A3 Modulators of cell-surface receptors of the ig-class |
| 01/05/2006 | WO2005054870A3 METHODS FOR ASSESSING p19-Arf INTERACTIONS WITH cMyc |
| 01/05/2006 | WO2005049073A3 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 01/05/2006 | WO2005035553A3 Conjugation of peptides |
| 01/05/2006 | WO2005016947A3 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 01/05/2006 | WO2005016280A3 Orally administered small peptides synergize statin activity |
| 01/05/2006 | WO2004097020A3 Rna interference mediated inhibition of map kinase gene expression |
| 01/05/2006 | WO2004078146A3 Trans-membrane-antibody induced inhibition of apoptosis |
| 01/05/2006 | WO2004071441A3 Compositions and methods to modulate immune and inflammatory responses |
| 01/05/2006 | WO2004053073A3 HIGH EFFICACY ANTISENSE Riα PKA POLY-DNP OLIGORIBONUCLEOTIDES |
| 01/05/2006 | WO2004024887A3 Centrosome proteins and uses thereof |
| 01/05/2006 | WO2004016737A3 Novel htnfsf13b protein variants |
| 01/05/2006 | WO2004008946A3 Methods of diagnosing and treating pre-eclampsia or clamp |
| 01/05/2006 | WO2004001005A3 Intracellular signaling proteins |
| 01/05/2006 | WO2003102153A3 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 01/05/2006 | WO2003095477A3 Miniprotein ligands and other polypeptides and methods for making and using same |
| 01/05/2006 | WO2003087338A3 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 01/05/2006 | WO2003042354A3 Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis |
| 01/05/2006 | WO2003031598A3 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060004456 Intervertebral disc treatment devices and methods |
| 01/05/2006 | US20060004186 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
| 01/05/2006 | US20060004184 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004019 Steroid sparing agents and methods of using same |
| 01/05/2006 | US20060003984 Monobactam compositions and methods of use thereof |
| 01/05/2006 | US20060003981 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
| 01/05/2006 | US20060003962 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 01/05/2006 | US20060003960 Tumor treatment |
| 01/05/2006 | US20060003954 Inhibiting the expression of a wild type COL1A1 gene to treat a lung disease relating to a collagen disorder |
| 01/05/2006 | US20060003952 Oligomeric compounds having modified phosphate groups |